Sudarshan Pharma Industries Ltd — Results, 14-08-2025: Result

Sudarshan Pharma Industries Ltd. has announced its financial results for the quarter ended June 30, 2025. The company reported a standalone net profit of INR 3.73 Cr and a consolidated net profit of INR 3.96 Cr. Revenue from operations stood at INR 142.31 Cr (standalone) and INR 145.26 Cr (consolidated). In significant developments, the company won a Dubai court case, securing an award of approximately INR 9.19 Cr. Additionally, it completed two strategic acquisitions: 51% of Ishwari Healthcare for INR 1.50 Cr and 100% of Cibachem General Trading LLC for INR 0.55 Cr, expanding its product offerings and market presence.